close video COVID moving into an endemic setting: Moderna CEO Stephane Bancel

Moderna CEO Stephane Bancel discusses the end stages of the COVID pandemic, booster shots, the company’s outlook for 2023, RSV vaccines, the melanoma trials and mRNA technology.

Modena CEO Stephane Bancel said coronavirus is transitioning from a pandemic to an endemic.

"It's tough to look precisely because none of us managed a transition from a pandemic to an endemic before. But we really think now that we're moving into an endemic setting," he told FOX Business’ Maria Bartiromo in an exclusive interview that aired on "Mornings with Maria" Tuesday.

Bancel went on to say the omicron booster resulted in "very good" clinical data in terms of vaccine efficacy. He expects $5 billion in vaccine sales in 2023. 

"I think we are now getting ready for yet another update in the fall, and we are going to move most probably to annual boosters for people at high risk."

Moderna CEO said the COVID pandemic is moving into an endemic. (Photo by JOSEPH PREZIOSO/AFP via Getty Images / Getty Images)

This is a developing story. Check back for updates.